Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Feng Yao, PH.D.

TitleAssistant Professor of Surgery
InstitutionBrigham and Women's Hospital
DepartmentSurgery
AddressBrigham and Women's Hospital
Plastic Surgery
75 Francis St
Boston MA 02115
Phone617/232-4836
Fax617/228-6918

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Akhrameyeva NV, Zhang P, Sugiyama N, Behar SM, Yao F. Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice. J Virol. 2011 May; 85(10):5036-47.
    View in: PubMed
  2. Koyama T, Hackl F, Aflaki P, Bergmann J, Zuhaili B, Waisbren E, Govindarajulu U, Yao F, Eriksson E. A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis. J Am Coll Surg. 2011 Mar; 212(3):340-8.
    View in: PubMed
  3. Xu XM, Wang YS, Chen RY, Feng CL, Yao F, Tong SS, Wang L, Yamashita F, Yu JN. Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice. Chem Pharm Bull (Tokyo). 2011; 59(2):260-5.
    View in: PubMed
  4. Brans R, Yao F. Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs. BMC Microbiol. 2010; 10:163.
    View in: PubMed
  5. Yao F, Murakami N, Bleiziffer O, Zhang P, Akhrameyeva NV, Xu X, Brans R. Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy. J Virol. 2010 Aug; 84(16):8163-71.
    View in: PubMed
  6. Reish RG, Zuhaili B, Bergmann J, Aflaki P, Koyama T, Hackl F, Waisbren E, Canseco JA, Verma KD, Eriksson E, Yao F. Modulation of scarring in a liquid environment in the Yorkshire pig. Wound Repair Regen. 2009 Nov-Dec; 17(6):806-16.
    View in: PubMed
  7. Brans R, Akhrameyeva NV, Yao F. Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1. J Invest Dermatol. 2009 Oct; 129(10):2470-9.
    View in: PubMed
  8. Hirsch T, Spielmann M, Zuhaili B, Fossum M, Metzig M, Koehler T, Steinau HU, Yao F, Onderdonk AB, Steinstraesser L, Eriksson E. Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med. 2009 Mar; 11(3):220-8.
    View in: PubMed
  9. Lu Z, Brans R, Akhrameyeva NV, Murakami N, Xu X, Yao F. High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection. J Invest Dermatol. 2009 May; 129(5):1174-84.
    View in: PubMed
  10. Hirsch T, Spielmann M, Velander P, Zuhaili B, Bleiziffer O, Fossum M, Steinstraesser L, Yao F, Eriksson E. Insulin-like growth factor-1 gene therapy and cell transplantation in diabetic wounds. J Gene Med. 2008 Nov; 10(11):1247-52.
    View in: PubMed
  11. Brans R, Eriksson E, Yao F. Immunization with a dominant-negative recombinant HSV type 1 protects against HSV-1 skin disease in guinea pigs. J Invest Dermatol. 2008 Dec; 128(12):2825-32.
    View in: PubMed
  12. Velander P, Theopold C, Hirsch T, Bleiziffer O, Zuhaili B, Fossum M, Hoeller D, Gheerardyn R, Chen M, Visovatti S, Svensson H, Yao F, Eriksson E. Impaired wound healing in an acute diabetic pig model and the effects of local hyperglycemia. Wound Repair Regen. 2008 Mar-Apr; 16(2):288-93.
    View in: PubMed
  13. Hirsch T, Spielmann M, Zuhaili B, Koehler T, Fossum M, Steinau HU, Yao F, Steinstraesser L, Onderdonk AB, Eriksson E. Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg. 2008; 8:5.
    View in: PubMed
  14. Vranckx JJ, Hoeller D, Velander PE, Theopold CF, Petrie N, Takedo A, Eriksson E, Yao F. Cell suspension cultures of allogenic keratinocytes are efficient carriers for ex vivo gene transfer and accelerate the healing of full-thickness skin wounds by overexpression of human epidermal growth factor. Wound Repair Regen. 2007 Sep-Oct; 15(5):657-64.
    View in: PubMed
  15. Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. Gene transfer strategies in tissue engineering. J Cell Mol Med. 2007 Mar-Apr; 11(2):206-23.
    View in: PubMed
  16. Yao F, Pomahac B, Visovatti S, Chen M, Johnson S, Augustinova H, Svensjo T, Eriksson E. Systemic and localized reversible regulation of transgene expression by tetracycline with tetR-mediated transcription repression switch. J Surg Res. 2007 Apr; 138(2):267-74.
    View in: PubMed
  17. Hirsch T, Spielmann M, Yao F, Eriksson E. Gene therapy in cutaneous wound healing. Front Biosci. 2007; 12:2507-18.
    View in: PubMed
  18. Yao F, Theopold C, Hoeller D, Bleiziffer O, Lu Z. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector. Mol Ther. 2006 Jun; 13(6):1133-41.
    View in: PubMed
  19. Petrie NC, Vranckx JJ, Hoeller D, Yao F, Eriksson E. Gene delivery of PDGF for wound healing therapy. J Tissue Viability. 2005 Nov; 15(4):16-21.
    View in: PubMed
  20. Vranckx JJ, Yao F, Petrie N, Augustinova H, Hoeller D, Visovatti S, Slama J, Eriksson E. In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen. 2005 Jan-Feb; 13(1):51-60.
    View in: PubMed
  21. Augustinova H, Hoeller D, Yao F. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice. J Virol. 2004 Jun; 78(11):5756-65.
    View in: PubMed
  22. Theopold C, Yao F, Eriksson E. Gene therapy in the treatment of lower extremity wounds. Int J Low Extrem Wounds. 2004 Jun; 3(2):69-79.
    View in: PubMed
  23. Petrie NC, Yao F, Eriksson E. Gene therapy in wound healing. Surg Clin North Am. 2003 Jun; 83(3):597-616, vii.
    View in: PubMed
  24. Svensjö T, Yao F, Pomahac B, Winkler T, Eriksson E. Cultured autologous fibroblasts augment epidermal repair. Transplantation. 2002 Apr 15; 73(7):1033-41.
    View in: PubMed
  25. Svensjö T, Pomahac B, Yao F, Slama J, Wasif N, Eriksson E. Autologous skin transplantation: comparison of minced skin to other techniques. J Surg Res. 2002 Mar; 103(1):19-29.
    View in: PubMed
  26. Yao F, Eriksson E. Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein. Antiviral Res. 2002 Feb; 53(2):127-33.
    View in: PubMed
  27. Hoeller D, Petrie N, Yao F, Eriksson E. Gene therapy in soft tissue reconstruction. Cells Tissues Organs. 2002; 172(2):118-25.
    View in: PubMed
  28. Yao F, Visovatti S, Johnson CS, Chen M, Slama J, Wenger A, Eriksson E. Age and growth factors in porcine full-thickness wound healing. Wound Repair Regen. 2001 Sep-Oct; 9(5):371-7.
    View in: PubMed
  29. Ogueta SB, Yao F, Marasco WA. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector. Mol Med. 2001 Aug; 7(8):569-79.
    View in: PubMed
  30. Svensjö T, Yao F, Pomahac B, Eriksson E. Autologous keratinocyte suspensions accelerate epidermal wound healing in pigs. J Surg Res. 2001 Aug; 99(2):211-21.
    View in: PubMed
  31. Yao F, Eriksson E. Gene therapy in wound repair and regeneration. Wound Repair Regen. 2000 Nov-Dec; 8(6):443-51.
    View in: PubMed
  32. Svensjö T, Pomahac B, Yao F, Slama J, Eriksson E. Accelerated healing of full-thickness skin wounds in a wet environment. Plast Reconstr Surg. 2000 Sep; 106(3):602-12; discussion 613-4.
    View in: PubMed
  33. Yao F, Eriksson E. A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Hum Gene Ther. 1999 Jul 20; 10(11):1811-8.
    View in: PubMed
  34. Yao F, Eriksson E. A novel tetracycline-inducible viral replication switch. Hum Gene Ther. 1999 Feb 10; 10(3):419-27.
    View in: PubMed
  35. Yao F, Svensjö T, Winkler T, Lu M, Eriksson C, Eriksson E. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther. 1998 Sep 1; 9(13):1939-50.
    View in: PubMed
  36. Eriksson E, Yao F, Svensjö T, Winkler T, Slama J, Macklin MD, Andree C, McGregor M, Hinshaw V, Swain WF. In vivo gene transfer to skin and wound by microseeding. J Surg Res. 1998 Aug; 78(2):85-91.
    View in: PubMed
  37. Pomahac B, Svensjö T, Yao F, Brown H, Eriksson E. Tissue engineering of skin. Crit Rev Oral Biol Med. 1998; 9(3):333-44.
    View in: PubMed
  38. Silver K, Walston J, Chung WK, Yao F, Parikh VV, Andersen R, Cheskin LJ, Elahi D, Muller D, Leibel RL, Shuldiner AR. The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes. 1997 Nov; 46(11):1898-900.
    View in: PubMed
  39. Yao F, Schaffer PA. Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4. J Virol. 1994 Dec; 68(12):8158-68.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Yao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_